Neumora Therapeutics Inc. Common Stock
NMRA | NASDAQ
$0.69
-$0.04 (-5.48%)
At close: Sep 21, 2026, 4:00 PM ET
$0.73
+$0.04 (+5.52%)
Pre-market:
Sep 22, 2026, 8:27 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 8K | n/a | 5M | n/a | n/a | n/a | n/a | n/a | n/a | 166K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -8K | n/a | -5M | n/a | n/a | n/a | n/a | n/a | n/a | -166K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -42.19M | -52.86M | -58.48M | -57.7M | -54.04M | -70.94M | -62.92M | -76.65M | -63.82M | -60.07M | -50.1M | -56.86M | -42.06M | -39.17M | -30.72M | -30.6M | -31.31M | -43.24M | -26.55M | -178.13M | -17.2M | -15.45M |
Interest Income | 935K | 1.23M | 1.34M | 1.69M | 1.81M | 3.07M | 4.09M | 4.21M | 5.27M | 6.37M | 5.65M | 3.84M | 3.56M | 3.57M | 2.29M | 1.41M | 784K | 86K | n/a | n/a | n/a | n/a |
Pretax Income | -43.08M | -53.43M | -59.45M | -56.76M | -52.71M | -67.89M | -58.82M | -72.49M | -58.58M | -53.72M | -108.46M | -53.03M | -38.54M | -35.63M | -28.15M | -29.34M | -30.37M | -43.04M | -26.97M | -178.03M | -17.01M | -15.3M |
Net Income | -43.08M | -53.46M | -59.45M | -56.76M | -52.73M | -67.99M | -58.82M | -72.55M | -58.7M | -53.72M | -108.73M | -53.03M | -38.54M | -35.63M | -28.15M | -29.34M | -30.37M | -43.04M | -26.97M | -178.03M | -17.01M | -15.3M |
Selling & General & Admin | 12.91M | 14.27M | 13.81M | 12.18M | 15.32M | 18.79M | 17.01M | 16.02M | 15.19M | 14.32M | 11.07M | 15.26M | 9.29M | 9.68M | 7.2M | 8.05M | 7.79M | 8.09M | 7.64M | 6.66M | 6.31M | 3.94M |
Research & Development | 29.28M | 38.6M | 44.67M | 40.52M | 38.72M | 52.15M | 45.91M | 60.63M | 48.63M | 45.76M | 38.86M | 41.6M | 32.77M | 29.49M | 23.52M | 22.55M | 23.53M | 35.15M | 18.91M | 171.47M | 10.89M | 11.5M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 42.19M | 52.86M | 58.48M | 52.7M | 54.04M | 70.94M | 62.92M | 76.65M | 63.82M | 60.07M | 49.93M | 56.86M | 42.06M | 39.17M | 30.72M | 30.6M | 31.31M | 43.24M | 26.55M | 178.13M | 17.2M | 15.45M |
Interest Expense | 1.82M | 1.85M | 2.04M | 747K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 42.19M | 52.86M | 58.48M | 57.7M | 54.04M | 70.94M | 62.92M | 76.65M | 63.82M | 60.07M | 50.1M | 56.86M | 42.06M | 39.17M | 30.72M | 30.6M | 31.31M | 43.24M | 26.55M | 178.13M | 17.2M | 15.45M |
Income Tax Expense | n/a | 30K | n/a | n/a | 25K | 105K | n/a | 53K | 125K | n/a | 268K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 185.16M | 179.87M | 163.39M | 161.84M | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | 158.83M | 155.39M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M |
Shares Outstanding (Diluted) | 185.16M | 179.87M | 163.39M | 161.84M | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | 158.83M | 155.39M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M |
EPS (Basic) | -0.23 | -0.30 | -0.35 | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | -0.68 | -0.34 | -0.25 | -0.23 | -0.19 | -0.19 | -0.20 | -0.28 | -0.18 | -1.17 | -0.11 | -0.10 |
EPS (Diluted) | -0.23 | -0.30 | -0.35 | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | -0.68 | -0.34 | -0.25 | -0.23 | -0.19 | -0.19 | -0.20 | -0.28 | -0.18 | -1.17 | -0.11 | -0.10 |
EBITDA | -42.18M | -51.57M | -57.41M | -55.99M | -52.69M | -67.73M | -58.66M | -72.34M | -58.42M | -53.56M | -108.3M | -52.85M | -38.37M | -35.47M | -28M | -29.2M | -30.22M | -42.9M | -26.84M | -177.88M | -16.89M | -15.31M |
EBIT | -42.18M | -51.57M | -57.41M | -56.01M | -52.71M | -67.89M | -58.82M | -72.49M | -58.58M | -53.72M | -108.46M | -53.03M | -38.54M | -35.63M | -28.15M | -29.34M | -30.37M | -43.04M | -26.97M | -178.03M | -17.01M | -15.45M |
Depreciation & Amortization | n/a | 8K | 9K | 23K | 19K | 157K | 157K | 156K | 160K | 158K | 166K | 173K | 171K | 158K | 147K | 146K | 154K | 147K | 131K | 150K | 125K | 132K |
Add to Watchlist
Select watchlists to add or remove NMRA